Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support : A Case Series
Thieme. All rights reserved..
OBJECTIVE: This study aimed to describe two cases of acute respiratory distress syndrome (ARDS) secondary to novel coronavirus disease 2019 (COVID-19) in pregnant women requiring extracorporeal membrane oxygenation (ECMO), and resulting in premature delivery.
STUDY DESIGN: The clinical course of two women hospitalized with ARDS due to COVID-19 care in our intensive care (ICU) is summarized; both participants provided consent to be included in this case series.
RESULTS: Both women recovered with no clinical sequelae. Neonatal outcomes were within the realm of expected for prematurity with the exception of coagulopathy. There was no vertical transmission to the neonates.
CONCLUSION: This case series highlights that ECMO is a feasible treatment in the pregnant woman with severe COVID-19 and that delivery can be performed safely on ECMO with no additional risk to the fetus. While ECMO carries its natural risks, it should be considered a viable option during pregnancy and the postpartum period.
KEY POINTS: · COVID-19 may present with a more severe course in pregnancy.. · ECMO may be used in pregnant woman with severe COVID-19.. · Delivery can be performed on ECMO without added fetal risk.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
---|---|
Enthalten in: |
American journal of perinatology - 38(2021), 1 vom: 02. Jan., Seite 82-87 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Douglass, K Marie [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 12.01.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1055/s-0040-1718694 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316386103 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316386103 | ||
003 | DE-627 | ||
005 | 20231225160953.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1055/s-0040-1718694 |2 doi | |
028 | 5 | 2 | |a pubmed24n1054.xml |
035 | |a (DE-627)NLM316386103 | ||
035 | |a (NLM)33069171 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Douglass, K Marie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Maternal-Neonatal Dyad Outcomes of Maternal COVID-19 Requiring Extracorporeal Membrane Support |b A Case Series |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.01.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Thieme. All rights reserved. | ||
520 | |a OBJECTIVE: This study aimed to describe two cases of acute respiratory distress syndrome (ARDS) secondary to novel coronavirus disease 2019 (COVID-19) in pregnant women requiring extracorporeal membrane oxygenation (ECMO), and resulting in premature delivery | ||
520 | |a STUDY DESIGN: The clinical course of two women hospitalized with ARDS due to COVID-19 care in our intensive care (ICU) is summarized; both participants provided consent to be included in this case series | ||
520 | |a RESULTS: Both women recovered with no clinical sequelae. Neonatal outcomes were within the realm of expected for prematurity with the exception of coagulopathy. There was no vertical transmission to the neonates | ||
520 | |a CONCLUSION: This case series highlights that ECMO is a feasible treatment in the pregnant woman with severe COVID-19 and that delivery can be performed safely on ECMO with no additional risk to the fetus. While ECMO carries its natural risks, it should be considered a viable option during pregnancy and the postpartum period | ||
520 | |a KEY POINTS: · COVID-19 may present with a more severe course in pregnancy.. · ECMO may be used in pregnant woman with severe COVID-19.. · Delivery can be performed on ECMO without added fetal risk | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Strobel, Katie M |e verfasserin |4 aut | |
700 | 1 | |a Richley, Michael |e verfasserin |4 aut | |
700 | 1 | |a Mok, Thalia |e verfasserin |4 aut | |
700 | 1 | |a de St Maurice, Annabelle |e verfasserin |4 aut | |
700 | 1 | |a Fajardo, Viviana |e verfasserin |4 aut | |
700 | 1 | |a Young, Andrew T |e verfasserin |4 aut | |
700 | 1 | |a Rao, Rashmi |e verfasserin |4 aut | |
700 | 1 | |a Lee, Lydia |e verfasserin |4 aut | |
700 | 1 | |a Benharash, Peyman |e verfasserin |4 aut | |
700 | 1 | |a Chu, Alison |e verfasserin |4 aut | |
700 | 1 | |a Afshar, Yalda |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of perinatology |d 1993 |g 38(2021), 1 vom: 02. Jan., Seite 82-87 |w (DE-627)NLM013020544 |x 1098-8785 |7 nnns |
773 | 1 | 8 | |g volume:38 |g year:2021 |g number:1 |g day:02 |g month:01 |g pages:82-87 |
856 | 4 | 0 | |u http://dx.doi.org/10.1055/s-0040-1718694 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 38 |j 2021 |e 1 |b 02 |c 01 |h 82-87 |